• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺皮质癌中预后相关的 mRNA 剪接变异。

Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.

机构信息

Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, The Second Affiliated Hospital, Cancer Institute, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Front Endocrinol (Lausanne). 2021 Mar 12;12:538364. doi: 10.3389/fendo.2021.538364. eCollection 2021.

DOI:10.3389/fendo.2021.538364
PMID:33776902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7994755/
Abstract

BACKGROUND

This paper aims to identify alternative RNA splicing landscape and its prognostic value in adrenocortical carcinoma.

METHODS

The alternative splicing events data with corresponding clinical information data of 79 ACC patients were obtained from the Cancer Genome Atlas and SpliceSeq package. Prognosis-associated AS events by using univariate Cox regression analysis were selected. Gene functional enrichment analysis demonstrated the potential pathways enriched by survival-associated AS. Prognosis-related splicing events were submitted to develop moderate predictors using Lasso regression model.

RESULTS

One thousand five survival-associated alternative splicing events were identified. The prognostic genes included , , . Functional enrichment analysis suggested that prognostic splicing events are associated with Wnt signaling pathway. A prediction model including 12 alternative splicing events was constructed by Lasso regression using train set. ROC analysis showed good performance of the prediction model in test set. Then, a nomogram integrating the clinical-pathological factors and riskscore was constructed for predicting 1- and 3-year survival rate.

CONCLUSION

Our data provide a comprehensive bioinformatics analysis of AS events in ACC, providing biomarkers for disease progression and a potentially rich source of novel therapeutic targets.

摘要

背景

本研究旨在确定肾上腺皮质癌中替代性 RNA 剪接图谱及其预后价值。

方法

从癌症基因组图谱和 SpliceSeq 包中获取了 79 例 ACC 患者的替代性剪接事件数据及其相应的临床信息数据。使用单因素 Cox 回归分析筛选与预后相关的 AS 事件。通过生存相关 AS 富集的基因功能分析,揭示了潜在的通路。通过 Lasso 回归模型,对预后相关的剪接事件进行了中度预测因子的构建。

结果

鉴定出 1500 个与生存相关的替代性剪接事件。预后相关基因包括、、。功能富集分析表明,预后剪接事件与 Wnt 信号通路相关。通过 Lasso 回归在训练集中构建了一个包含 12 个替代性剪接事件的预测模型。ROC 分析显示,该预测模型在测试集中具有良好的性能。然后,构建了一个包含临床病理因素和风险评分的列线图,用于预测 1 年和 3 年的生存率。

结论

本研究提供了 ACC 中 AS 事件的全面生物信息学分析,为疾病进展提供了生物标志物,并为潜在的新型治疗靶点提供了丰富的来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/8ad6f79d2255/fendo-12-538364-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/c7192ec41b8d/fendo-12-538364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/3301b9422c16/fendo-12-538364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/ed8fc1a76281/fendo-12-538364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/56a09e5ee7ca/fendo-12-538364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/044c08b4a604/fendo-12-538364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/a47d7fb3ca79/fendo-12-538364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/8ad6f79d2255/fendo-12-538364-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/c7192ec41b8d/fendo-12-538364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/3301b9422c16/fendo-12-538364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/ed8fc1a76281/fendo-12-538364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/56a09e5ee7ca/fendo-12-538364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/044c08b4a604/fendo-12-538364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/a47d7fb3ca79/fendo-12-538364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb22/7994755/8ad6f79d2255/fendo-12-538364-g007.jpg

相似文献

1
Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.肾上腺皮质癌中预后相关的 mRNA 剪接变异。
Front Endocrinol (Lausanne). 2021 Mar 12;12:538364. doi: 10.3389/fendo.2021.538364. eCollection 2021.
2
Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.基于 TCGA SpliceSeq 数据鉴定肾上腺皮质癌中与生存相关的可变剪接事件和特征。
Aging (Albany NY). 2020 Mar 26;12(6):4996-5009. doi: 10.18632/aging.102924.
3
Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.基于 m6A RNA 甲基化调控因子的签名构建与验证:用于预测肾上腺皮质癌患者预后
Front Endocrinol (Lausanne). 2021 Feb 22;12:568397. doi: 10.3389/fendo.2021.568397. eCollection 2021.
4
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.基于癌症基因组图谱(TCGA)和SpliceSeq数据库的胃癌预后中可变剪接特征的综合分析
Med Sci Monit. 2020 Nov 21;26:e925772. doi: 10.12659/MSM.925772.
5
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
6
Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.m6A RNA 甲基化调控因子在肾上腺皮质癌进展和预后中的作用的生物信息学分析和实验验证。
Aging (Albany NY). 2021 Apr 21;13(8):11919-11941. doi: 10.18632/aging.202896.
7
Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.剪接事件作为葡萄膜黑色素瘤预后的指标。
Genes (Basel). 2020 Feb 21;11(2):227. doi: 10.3390/genes11020227.
8
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
9
Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.m6A RNA 甲基化调节剂在肾上腺皮质癌中的表达模式及预后价值。
Medicine (Baltimore). 2021 Mar 12;100(10):e25031. doi: 10.1097/MD.0000000000025031.
10
Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.构建成人肾上腺皮质癌的稳健预后模型:生物信息学和真实世界数据的结果。
J Cell Mol Med. 2021 Apr;25(8):3898-3911. doi: 10.1111/jcmm.16323. Epub 2021 Feb 24.

引用本文的文献

1
Editorial: The RNA revolution and cancer.社论:RNA 革命与癌症。
Front Endocrinol (Lausanne). 2024 May 20;15:1422599. doi: 10.3389/fendo.2024.1422599. eCollection 2024.
2
Biological Implications of a Stroke Therapy Based in Neuroglobin Hyaluronate Nanoparticles. Neuroprotective Role and Molecular Bases.基于神经球蛋白透明质酸纳米粒子的中风治疗的生物学意义。神经保护作用和分子基础。
Int J Mol Sci. 2021 Dec 27;23(1):247. doi: 10.3390/ijms23010247.
3
Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer.

本文引用的文献

1
Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer.细胞色素C氧化酶亚基4(COX4):治疗甲状腺髓样癌的潜在治疗靶点。
Cancers (Basel). 2020 Sep 8;12(9):2548. doi: 10.3390/cancers12092548.
2
In-depth mining of clinical data: the construction of clinical prediction model with R.临床数据的深度挖掘:使用R构建临床预测模型。
Ann Transl Med. 2019 Dec;7(23):796. doi: 10.21037/atm.2019.08.63.
3
Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma.
甲状腺乳头状癌预后替代剪接特征的综合分析揭示复发预测因子
Front Oncol. 2021 Oct 13;11:705929. doi: 10.3389/fonc.2021.705929. eCollection 2021.
4
Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.利用网络分析鉴定甲状腺乳头状癌免疫浸润和预后中的铁死亡基因
BMC Genomics. 2021 Jul 27;22(1):576. doi: 10.1186/s12864-021-07895-6.
固醇O-酰基转移酶1作为肾上腺皮质癌的预后标志物
Cancers (Basel). 2020 Jan 19;12(1):247. doi: 10.3390/cancers12010247.
4
Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination.血清CA125、CA19-9、CA72-4及纤维蛋白原与淋巴细胞比值在胃癌腹膜播散中的临床意义
Front Oncol. 2019 Nov 5;9:1159. doi: 10.3389/fonc.2019.01159. eCollection 2019.
5
Survival analysis: part II - applied clinical data analysis.生存分析:第二部分 - 应用临床数据分析。
Korean J Anesthesiol. 2019 Oct;72(5):441-457. doi: 10.4097/kja.19183. Epub 2019 May 17.
6
ATXN2L upregulated by epidermal growth factor promotes gastric cancer cell invasiveness and oxaliplatin resistance.表皮生长因子上调 ATXN2L 促进胃癌细胞侵袭和奥沙利铂耐药性。
Cell Death Dis. 2019 Feb 20;10(3):173. doi: 10.1038/s41419-019-1362-2.
7
Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.肾上腺皮质癌生存预测因素分析:来自国家癌症数据库的研究。
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3566-3573. doi: 10.1210/jc.2018-00918.
8
Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.抑制 microRNA-16 通过 NF-κB 信号通路靶向 IKBKB 促进肝癌对紫杉醇的耐药性。
Biochem Biophys Res Commun. 2018 Sep 5;503(2):1035-1041. doi: 10.1016/j.bbrc.2018.06.113. Epub 2018 Aug 2.
9
The homeodomain transcription factor MEIS1 triggers chemokine expression and is involved in CD8+ T-lymphocyte infiltration in early stage ovarian cancer.同源域转录因子 MEIS1 触发趋化因子表达,并参与早期卵巢癌中 CD8+ T 淋巴细胞浸润。
Mol Carcinog. 2018 Sep;57(9):1251-1263. doi: 10.1002/mc.22840. Epub 2018 Jun 7.
10
MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.MEIS1 和 MEIS2 的表达与前列腺癌进展:HOXB13 结合伴侣在转移疾病中的作用。
Clin Cancer Res. 2018 Aug 1;24(15):3668-3680. doi: 10.1158/1078-0432.CCR-17-3673. Epub 2018 May 1.